Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage

Stroke

Volumn 45, Issue 9, 2014, Pages 2643-2648

  Pasquini, Marta ^a,b   Charidimou, Andreas ^c   Van Asch, Charlotte J J ^d   Baharoglu, Merih I ^e   Samarasekera, Neshika ^f   Werring, David J ^c   Klijn, Catharina J M ^d   Roos, Yvo B ^e   Salman, Rustam Al Shahi ^f   Cordonnier, Charlotte ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

antithrombotic agents; cerebral hemorrhage; cohort studies

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; FEMALE; FRANCE; HOSPITAL DISCHARGE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NETHERLANDS; REGRESSION ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PATIENT DISCHARGE; REGRESSION ANALYSIS; SCOTLAND; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84906809667     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006202     Document Type: Article

References (21)

1. Béjot Y, Cordonnier C, Durier J, Aboa-Eboulé C, Rouaud O, Giroud M. Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study. Brain. 2013;136(pt 2):658-664.
2. Lovelock CE, Molyneux AJ, Rothwell PM; Oxford Vascular Study. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6:487-493.
3. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344:d8059.
4. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC; German Stroke Study Collaboration. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis. 2011;32:283-288.
5. Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, et al. Use of aspirin in Chinese after recovery from primary intracranial haemorrhage. Thromb Haemost. 2012;107:241-247.
6. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke. 2010;41:2606-2611.
7. Viswanathan A, Rakich SM, Engel C, Snider R, Rosand J, Greenberg SM, et al. Antiplatelet use after intracerebral hemorrhage. Neurology. 2006;66:206-209.
8. Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693-698.
9. Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol. 2008;65:1313-1318.
10. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Longterm prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002;59:205-209.
11. Gathier CS, Algra A, Rinkel GJ, van der Worp HB. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy. Cerebrovasc Dis. 2013; 36:33-37.
12. Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol. 2012;28:33-39.
13. Molina CA, Selim MH. The dilemma of resuming anticoagulation after intracranial hemorrhage: little evidence facing big fears. Stroke. 2011;42:3665-3666.
14. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, et al. Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294-316.
15. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
16. Cordonnier C, Rutgers MP, Dumont F, Pasquini M, Lejeune JP, Garrigue D, et al. Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospitaland population-based registries? J Neurol. 2009;256:198-202.
17. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370: 1453-1457.
19. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
20. Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130:1390-1396.
21. Flaherty ML, Adeoye O, Sekar P, Haverbusch M, Moomaw CJ, Tao H, et al. The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. Stroke. 2009;40:1738-1742.